Skip to main content
. 2019 Nov 1;98(44):e17794. doi: 10.1097/MD.0000000000017794

Figure 1.

Figure 1

(A) Serum electrophoresis before treatment initiation demonstrating a monoclonal M-paraprotein of 0.61 g/dL. (B) Cerebrospinal fluid (CSF) electrophoresis showing a monoclonal component in the gamma region; immunofixation revealed immunoglobulin M and kappa light-chain monoclonal bands. (C) Serum electrophoresis after 6 months of treatment initiation showing disappearance of the monoclonal band, whereas serum immunofixation was negative.